New data presented today1,2, indicate that preoperative (neoadjuvant) treatment with ARIMIDEXTM (anastrozole) results in clinically beneficial reductions in tumour volume, extending the range of ...

Robertson, JF, Llombart-Cussac, A, Rolski, J, et al. Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study.

Treatment of advanced breast cancer. It’s given when your disease has progressed, even after early response with the cancer drug tamoxifen. Anastrozole doesn’t work well in women with estrogen ...

Anastrozole has clear long-term superior efficacy over tamoxifen, and the benefits of treatment with anastrozole are maintained long after treatment is completed, according to an article in the ...

In studies, taking Arimidex with tamoxifen was not a more effective treatment option than taking tamoxifen alone. And taking both drugs increased the risk of side effects from treatment.

If you have been taking Arimidex for 5 years, you may have fewer mild side effects than someone who recently started treatment. This is because some mild side effects last a short time.

Sept. 23, 2003 (Copenhagen) — The risk of bone fracture associated with the use of anastrozole for treatment of early breast cancer in postmenopausal women appears to reach a plateau and does ...

The drug, anastrozole, has been available for years as a breast cancer treatment, and had already been recommended for prevention by the UK's health cost regulator. But it has become the first ...

Remission of Macroglobulinemia during Anastrozole Treatment for Breast Cancer. Published April 21, 2005. N Engl J Med 2005; 352: 1725-1726. DOI: 10.1056/NEJM200504213521623. VOL. 352 NO. 16.

Anastrozole, a breast cancer treatment drug, is now available to 289,000 women in England as a cancer preventative. Here, MailOnline answers your questions about the daily pill.

And at just 4p per pill, compared to the thousands of pounds that cancer treatment costs, anastrozole is a bargain for the NHS. You might think this is wholly wonderful news.

International Journal of Impotence Research - Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole Skip to main content Thank you for visiting nature.com.